Polyrizon Ltd. Ordinary Shares

PLRZ XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

26M

Short interest (May 15)

2.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

126.11%

↓ 40.9%

Available Shares

200K

↓ 22.6%

Price Chart

Company Overview

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.

Company Info

Exchange: NASDAQ

CIK: 0001893645

Asset Type: CS

Market Data

Market Cap: $26,374,338

Employees: 1

Status: Active

Short Interest

Current Borrow Fee 126.11%

Range: 126.11% - 130.39%

Available Shares 200K

Range: 150K - 200K

Recent Changes

Fee Change: ↓ 9.7%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime